These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 25491139)

  • 1. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions.
    Lee YC; Knox BS; Garrett JE
    Aust N Z J Med; 1999 Dec; 29(6):765-9. PubMed ID: 10677119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
    Kuralay F; Tokgöz Z; Cömlekci A
    Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.
    Liao ND; Lee WY
    Cancer Cytopathol; 2012 Aug; 120(4):269-75. PubMed ID: 22367930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
    Wang M; Zhang Z; Wang X
    Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.
    Braunschweig T; Chung JY; Choi CH; Cho H; Chen QR; Xie R; Perry C; Khan J; Hewitt SM
    Diagn Pathol; 2015 May; 10():53. PubMed ID: 26022333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY
    Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
    Liao ND; Chiang TA; Lee WY
    Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic implications of telomerase activity in pleural effusions.
    Dikmen G; Dikmen E; Kara M; Sahin E; Doğan P; Ozdemir N
    Eur Respir J; 2003 Sep; 22(3):422-6. PubMed ID: 14516130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions.
    Xu F; Chen J; Shen HH; Wang XD; Shan J
    J Zhejiang Univ Sci; 2004 Oct; 5(10):1286-9. PubMed ID: 15362202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
    Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
    Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
    Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
    Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
    Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
    Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
    Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemistry and ELISA quantitation of mucin for diagnosis of malignant pleural effusions.
    Yang PC; Luh KT; Kuo SH; Wu CW
    Am Rev Respir Dis; 1992 Dec; 146(6):1571-5. PubMed ID: 1456577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.